Using diabetic patients once daily fingerprick autologous blood eye drops for diabetic dry eye disease- A modified regimen to treat and prevent diabetic dry eye disease

Using diabetic patients once daily fingerprick autologous blood eye drops for diabetic dry eye disease- A modified regimen to treat and prevent diabetic dry eye disease

Ming Chen, MD, MSc, FACS

University of Hawaii, Honolulu, Hawaii. USA

Purpose: Diabetic patients tend to suffer from dry eye disease due to associated various reasons.  Autologous blood is both safe and effective for treating Dry Eye Disease (DED) according to studies. Several papers demonstrated feasibility and effectiveness of four times Fingerprick Autologous Blood (FAB) eye drops to treat dry eye disease. As some diabetic patients perform daily finger pricking to monitor blood glucose level, the blood that remains can be used to apply to eyes to treat and prevent dry eye disease. This study intends to investigate if once daily fingerprick autologous blood eye drop in conjunction with blood glucose test is feasible and effective for diabetic patients who suffer from mild to moderate dry eye disease also to avoid four times fingerprick.  This may be the first study on using diabetic patients once daily fingerprick autologous blood eye drops for mild to moderate diabetic’s dry eye disease.

Design, setting and participants: This case series study enrolled 25 diabetics patients with mild to moderate DED who received ophthalmological care at a single clinic in Honolulu, Hawaii. All patients were performing once daily finger prick tests to monitor their blood glucose level. Participants were instructed to instill the remaining FAB after blood glucose tests into the medial inner canthus of each eye for one month. Patients remained on their daily dry eye treatment regimen throughout the study.

Main outcomes and measures: The OSDI (Ocular Surface Disease Index) scores to categorize severity of DED were used for comparison before and after using FAB eye drop daily for one month. A questionnaire was used to evaluate the acceptability and compliance.

Result: 52% of patients after one month of the trial demonstrated improvement in categorization of the severity in DED and willing to continue in the future.

Conclusion and relevance: FAB that remained after routine once daily blood glucose testing applied to the eyes may be feasible to enhance prevention and treatment of mild to moderate Diabetic DED. It may be disseminated and used in conjunction with the general practice in diabetic’s patient care.

Keywords: autologous blood, finger prick, dry eye disease, diabetic. Ocular surface Disease Index

Free Full-text PDF

How to cite this article:

Ming Chen. Using diabetic patients once daily fingerprick autologous blood eye drops for diabetic dry eye disease- A modified regimen to treat and prevent diabetic dry eye disease. International Journal of Case Reports, 2023, 7:285. DOI: 10.28933/ijcr-2022-01-0305mc

References:

1. Manaviat M. R., Rashidi M., Afkhami-Ardekani M., Shoja M. R. Prevalence of dry eye syndrome and diabetic retinopathy type 2 diabetic patients. BMC Ophthalmology. 2008;8, article 10 Doi: 10.1186/1471-2415-8-10.
2. Seifart U., Strempel I. The dry eye and diabetes mellitus. Ophthalmology. 1994;91(2):235–239.
3. Vaughan and Asbury’s general ophthalmology, 17th edition. Clinical and Experimental Optometry. 2008;91(6):577–577.doi: 10.1111/j.1444-0938.2008.00309. x.
4. Gekka M., Miyata K., Nagai Y., et al. Corneal epithelial barrier function in diabetic patients. Cornea. 2004;23(1):35–37.doi: 10.1097/00003226-200401000-00006.
5. Nakata M., Okada Y., Kobata H., et al. Diabetes mellitus suppresses hemodialysis-induced increases in tear fluid secretion. BMC Research Notes. 2014;7(1, article 78) Doi: 10.1186/1756-0500-7-78.
6. Than J, Balal S, Wawtznski J et al Fingerprick autologous blood: A novel treatment for dry eye syndrome, Eye (lond).2017 Dec;31(12): 1655-1663
7. Erikitola 0, Fern A, Lyall D Fingerprick autologous blood in the treatment of severe dry eyes and ocular surface disease Cornea 2021;40: 1104-1109
8. Soni NG, Jeng BH Blood-derived topical therapy for ocular surface disease, Br J ophthalmol 2016;100:22-27
9. Esquennazi S, He J, Bazan HEP et al. Use of autologous serum in corneal epithelial defects post-lamellar surgery. Cornea 2005; 248:992-997
10. Kojima T, Higuchi A, Goto E et al. Autologous serum eye drops for the treatment of dry eye disease Cornea 2008;27(suppl 1): S25-S30
11. Poon AC, Geerling D, Dart JKG, et al. Autologous serum eye-drops for dry eye and epithelial defects: clinical and in vitro toxicity studies. B j Ophthalmol 2001;85;1188-1197
12. Geerling G, Hartwig D, Autologous serum eye drops for ocular surface disease, A literature review and recommendations for their application Ophthalmology 2002;99;949-959
13. Lekhanont K, Jongkhajompong P, Choubtum L, et al. Topical 100% serum eye drops for treating corneal epithelial defect after ocular surgery, Biomed Res Int.2013;2013;521315
14. Azari AA, Rapuano CJ, Autologous serum eye drops for the treatment of ocular surface disease. Eye Contact lens 2015; 41:133-140
15. Imanishi j, Kamiyama K, Iguchi I, et al. Growth factors: importance in wound healing and maintenance of transparency of the cornea Prog Retin Eye Res.2000;19:113-129
16. Schiffman RM. Reliability and Validity of the Ocular Surface Disease Index. Archives of Ophthalmology. 2000;118(5):615-621.
17. Bron A, Evans VE, Smith JA. (2003). Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 22(7): 640-50.
18. Hassan A, Balal S, Cook Erica et al. Finger-prick autologous blood(FAB) eye drops for dry eye disease: Single masked multi-center randomized controlled trial, Clinical Ophthalmology2022:16 3973-3979